Plasmapheresis and immunoadsorption in patients with steroid refractory multiple sclerosis relapses

Journal of Neurology

Volumn 263, Issue 6, 2016, Pages 1092-1098

  Faissner, Simon ^a   Nikolayczik, Johanna ^a   Chan, Andrew ^a   Hellwig, Kerstin ^a   Gold, Ralf ^a   Yoon, Min Suk ^a   Haghikia, Aiden ^a  

^a ST JOSEF HOSPITAL   (Germany)

Author keywords

Immunoadsorption; Immunosuppressive treatment; Multiple sclerosis; Plasma exchange

Indexed keywords

STEROID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; IMMUNOADSORPTION; LATENT PERIOD; MALE; MULTIPLE SCLEROSIS; PLASMAPHERESIS; PRIORITY JOURNAL; RELAPSE; REMISSION; STEROID THERAPY; VISUAL ACUITY; VISUAL EVOKED POTENTIAL; APHERESIS; DISABILITY; DRUG RESISTANCE; INTRAVENOUS DRUG ADMINISTRATION; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY; PROCEDURES; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADMINISTRATION, INTRAVENOUS; ADULT; BLOOD COMPONENT REMOVAL; COMBINED MODALITY THERAPY; DISABILITY EVALUATION; DRUG RESISTANCE; EVOKED POTENTIALS, VISUAL; FEMALE; HUMANS; IMMUNOSORBENT TECHNIQUES; MALE; MULTIPLE SCLEROSIS; PLASMAPHERESIS; RETROSPECTIVE STUDIES; STEROIDS; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 84961999832     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-016-8105-4     Document Type: Article

References (14)

1. Haghikia A, Hohlfeld R, Gold R, Fugger L (2013) Therapies for multiple sclerosis: translational achievements and outstanding needs. Trends Mol Med 19:309–319. doi:10.1016/j.molmed.2013.03.004
2. Szczepiorkowski ZM, Winters JL, Bandarenko N, Kim HC, Linenberger ML, Marques MB et al (2010) Guidelines on the use of therapeutic apheresis in clinical practice–evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher 25:83–177. doi:10.1002/jca.20240
3. Weinshenker BG, O’Brien PC, Petterson TM, Noseworthy JH, Lucchinetti CF, Dodick DW et al (1999) A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 46:878–886
4. Köhler W, Bucka C, Klingel R (2011) A randomized and controlled study comparing immunoadsorption and plasma exchange in myasthenic crisis. J Clin Apher 26(6):347–355
5. Koziolek MJ, Kitze B, Mühlhausen J, Müller GA (2013) Immunoadsorption in steroid-refractory multiple sclerosis. Atheroscler Suppl 14:175–178. doi:10.1016/j.atherosclerosissup.2012.10.026
6. Munemoto M, Otaki Y, Kasama S, Nanami M, Tokuyama M, Yahiro M et al (2011) Therapeutic efficacy of double filtration plasmapheresis in patients with anti-aquaporin-4 antibody-positive multiple sclerosis. J Clin Neurosci 18:478–480. doi:10.1016/j.jocn.2010.07.141
7. Yoon MS, Chan A, Gold R (2011) Standard and escalating treatment of chronic inflammatory demyelinating polyradiculoneuropathy. Ther Adv Neurol Disord 4(3):193–200
8. Kaynar L, Altuntas F, Aydogdu I, Turgut B, Kocyigit I, Hacioglu SK et al (2008) Therapeutic plasma exchange in patients with neurologic diseases: retrospective multicenter study. Transfus Apher Sci 38:109–115. doi:10.1016/j.transci.2007.11.002
9. Cortese I, Chaudhry V, So YT, Cantor F, Cornblath DR, Rae-Grant A (2011) Evidence-based guideline update: plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 76:294–300. doi:10.1212/WNL.0b013e318207b1f6
10. Khatri BO, Man S, Giovannoni G, Koo AP, Lee J, Tucky B et al (2009) Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function. Neurology 72:402–409. doi:10.1212/01.wnl.0000341766.59028.9d
11. Wenning W, Haghikia A, Laubenberger J, Clifford DB, Behrens PF, Chan A et al (2009) Treatment of progressive multifocal leukoencephalopathy associated with natalizumab. N Engl J Med 361:1075–1080. doi:10.1056/NEJMoa0810257
12. Heigl F, Hettich R, Arendt R, Durner J, Koehler J, Mauch E (2013) Immunoadsorption in steroid-refractory multiple sclerosis: clinical experience in 60 patients. Atheroscler Suppl 14(1):167–173
13. Yeh J, Wang S, Chien P, Shih C, Chiu H (2009) Changes in serum cytokine levels during plasmapheresis in patients with myasthenia gravis. Eur J Neurol 16:1318–1322. doi:10.1111/j.1468-1331.2009.02729.x
14. Goto H, Matsuo H, Nakane S, Izumoto H, Fukudome T, Kambara C et al (2001) Plasmapheresis affects T helper type-1/T helper type-2 balance of circulating peripheral lymphocytes. Ther Apher 5:494–496